NH · NSE
Narayana Hrudayalaya Ltd.
₹1,928.5
+3.21% (+₹59.9)
Prev. close
₹1,868.6
Volume
2,71,767
Delivery %
68.5%
As of
18 Sept 2026
Price history
No analyst calls on this stock in the last 90 days yet.
Explore by date range →Analyst opinions
Fundamentals
About Narayana Hrudayalaya Ltd.
Narayana Hrudayalaya Limited provides medical and healthcare services in India, the United Kingdom, and the Cayman Islands. It operates through the Medical and Healthcare Related Services; and Others segments. The company offers oncology, anesthesiology, audiology, blood bank, breast oncology, oncoplastic surgery, cardiac surgery, cardiology, clinical genetics, clinical immunology, clinical nutrition and dietetics, clinical psychology, congenital adult heart disease, cosmetology, cranio-maxillofacial surgery, critical care medicine, dental, dermatology, diabetology, ENT, emergency medicine, endocrinology, family medicine, general and GI surgery, general medicine and surgery, geriatric medicine, gynecology, hematology, headache and facial pain management, transplant, infectious diseases, neurology, radiology, hepatobiliary surgery, gastroenterology, minimal access GI and bariatric surgery, neonatology, nephrology, neuro-otology, neuro-rehabilitation, neurosurgery and spine surgery, and nuclear medicine services. It also provides ophthalmology, orthopedics and joint replacement, pain management and palliative care, pathology, perinatology and fetal intervention, physical medicine and rehabilitation, physiotherapy and physical rehabilitation, plastic surgery, psychiatry, pulmonology, reproductive medicine, rheumatology, renal science, speech and swallow rehabilitation, spine surgery, thoracic and vascular surgery, uro oncology, urology, and other services. In addition, the company acquires, owns, and operates hospitals, clinics, health centers, diagnostic centers, and nursing homes. Further, it provides health insurance, consultancy services in the field of healthcare and hospitals, and IT services related to healthcare. Additionally, the company engages in investment activities; and develops software related to the healthcare industry. The company was incorporated in 2000 and is headquartered in Bengaluru, India.
Details
Sector
Healthcare
Industry
Medical Care Facilities
CEO
Dr. Emmanuel Rupert
Headquarters
Bengaluru
Employees
11,234
Website
narayanahealth.orgExchange
View on NSE ↗Key stats
Market cap
₹39,167.80 Cr
P/E ratio (TTM)
47.8
Dividend yield
0.24%
EPS (TTM)
₹40.36
Beta (1Y · daily vs NIFTY 50)
0.77
Beta (5Y · monthly vs NIFTY 50)
0.85
Shares float
6.60 Cr
EPS · quarter ended Jun 2026
₹10.20
Financial Performance
01 · Financials
FY22 growth needs FY21 filings, which the data source doesn't provide.
02 · Earnings Per Share (EPS)
03 · Dividend Profile
Growth compares completed fiscal-year dividend totals on the company's own calendar: April–March (Indian FY), taken from its reported period-ends. Payout ledger: NSE corporate actions.
04 · Operating Efficiency (Growth Rates)
Balance-sheet-based · pre-FY23 not filed in verifiable form
05 · Capital Structure & Asset Utilization
Pre-FY23 not filed in verifiable form
Asset turnover needs a prior year of assets — omitted for the earliest available year.
06 · Asset Base Composition
Pre-FY23 not filed in verifiable form
07 · Debt Level & Coverage
Pre-FY23 not filed in verifiable form
08 · Profit & Loss
Annual
| Line item | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|---|
| ₹2,582.35 Cr | ₹3,701.32 Cr | ₹4,524.77 Cr | ₹5,018.25 Cr | ₹5,482.98 Cr | ₹7,896.04 Cr | |
| EBITDA | ₹203.44 Cr | ₹679.56 Cr | ₹1,031.08 Cr | ₹1,227.55 Cr | ₹1,360.06 Cr | ₹1,665.94 Cr |
| ₹-14.30 Cr | ₹341.93 Cr | ₹606.25 Cr | ₹789.26 Cr | ₹790.16 Cr | ₹805.60 Cr | |
| Diluted EPS | ₹-0.7 | ₹16.84 | ₹29.85 | ₹38.86 | ₹38.9 | ₹39.67 |
09 · Balance Sheet
Annual
| Line item | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|---|
| ₹2,770.02 Cr | ₹3,130.53 Cr | ₹4,162.09 Cr | ₹5,624.58 Cr | ₹7,265.03 Cr | ₹12,474.40 Cr | |
| ₹825.64 Cr | ₹723.42 Cr | ₹884.17 Cr | ₹1,626.69 Cr | ₹2,428.37 Cr | ₹5,857.50 Cr | |
| Stockholders' equity | ₹1,120.28 Cr | ₹1,488.64 Cr | ₹2,131.38 Cr | ₹2,883.68 Cr | ₹3,626.36 Cr | ₹4,537.26 Cr |
Trade receivables, CWIP, Others, Long-term debt, Current (short-term) debt have filed figures for only some of the years shown — no further verified source covers the rest, so those years are left blank rather than estimated.
Annual only — the data source doesn’t publish quarterly balance-sheet detail for most NSE-listed companies.
10 · Cash Flow Statement
Annual
| Line item | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|---|
| ₹309.05 Cr | ₹485.02 Cr | ₹1,084.56 Cr | ₹1,066.60 Cr | ₹990.08 Cr | ₹1,618.46 Cr | |
| Investing cash flow | ₹-112.99 Cr | ₹-266.91 Cr | ₹-1,174.10 Cr | ₹-1,457.94 Cr | ₹-1,317.12 Cr | ₹-3,699.90 Cr |
| ₹-198.43 Cr | ₹-158.95 Cr | ₹87.74 Cr | ₹488.45 Cr | ₹544.31 Cr | ₹2,342.93 Cr | |
| Capital expenditure | ₹-70.10 Cr | ₹-250.68 Cr | ₹-522.04 Cr | ₹-970.61 Cr | ₹-1,073.76 Cr | ₹-874.94 Cr |
| End cash position | ₹89.51 Cr | ₹148.53 Cr | ₹144.59 Cr | ₹241.74 Cr | ₹447.16 Cr | ₹760.57 Cr |
Debt issued, Debt repaid have filed figures for only some of the years shown — no further verified source covers the rest, so those years are left blank rather than estimated.
Annual only — the data source has no quarterly cash-flow-statement coverage.
11 · Shareholding Pattern
NSE, quarterly
| Line item | Sep 21–Mar 22(3Q) | Jun 22–Sep 22(2Q) | Dec 22–Jun 23(3Q) | Sep 23–Sep 25(9Q) | Dec 25–Jun 26(3Q) |
|---|---|---|---|---|---|
| Promoter | 63.85% | 63.85% | 63.85% | 63.85% | 63.27% |
| Public | 35.45% | 35.46% | 35.52% | 35.53% | 36.11% |
| Employee trusts | 0.70% | 0.69% | 0.63% | 0.62% | 0.62% |
Source: NSE quarterly shareholding-pattern filings, collapsed to periods where the reported percentages held steady — a column spanning several quarters means no change was filed across them. No FII/DII sub-split available from this source — Public includes all non-promoter, non-employee-trust holders.
12 · Peer Comparison
Healthcare
| Company | ||||||||
|---|---|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Limited | ₹4.48 L Cr | ₹1,837.3 | 37.0 | 5.36 | 13.7% | 0.06 | +11.9% | +11.4% |
| Divi's Laboratories Limited | ₹2.47 L Cr | ₹9,375 | 83.3 | 14.77 | 15.3% | 0.00 | +12.3% | +53.4% |
| Torrent Pharmaceuticals Limited | ₹1.83 L Cr | ₹4,875 | 76.9 | 21.82 | 25.8% | 1.79 | +21.5% | +37.4% |
| Apollo Hospitals Enterprise Limited | ₹1.26 L Cr | ₹8,944.5 | 60.4 | 13.30 | 20.5% | 0.90 | +15.7% | +13.9% |
| Lenskart Solutions Limited | ₹1.18 L Cr | ₹707.2 | 179.9 | 13.48 | 5.6% | 0.35 | +35.4% | — |
| Zydus Lifesciences Limited | ₹1.13 L Cr | ₹1,160 | 25.3 | 4.18 | 18.6% | 0.46 | +18.4% | +10.7% |
| Cipla Limited | ₹1.10 L Cr | ₹1,376.3 | 32.5 | 3.19 | 11.3% | 0.02 | +2.1% | -11.8% |
| Laurus Labs Limited | ₹1.05 L Cr | ₹1,954 | 96.4 | 19.86 | 16.8% | 0.48 | +22.0% | +111.6% |
| Max Healthcare Institute Limited | ₹1.01 L Cr | ₹1,049.3 | 69.8 | 9.39 | 13.4% | 0.32 | +19.0% | -10.6% |
| Dr. Reddy's Laboratories Limited | ₹97,876.16 Cr | ₹1,185 | 29.6 | 2.60 | 11.4% | 0.21 | +3.2% | -10.4% |
| Manipal Health Enterprises Limited | ₹97,364.22 Cr | ₹738.95 | 146.6 | 11.56 | 7.8% | 1.53 | +18.0% | — |
| Narayana Hrudayalaya Ltd. | ₹37,605.97 Cr | ₹1,868.6 | 45.9 | 8.29 | 17.8% | 1.29 | +43.8% | +3.4% |
Ranked by market cap within Healthcare, same metrics as the Fundamentals screener. Click a column to sort.
Documents
IPO documents
Annual reports
Show all 11
Concall transcripts
Show all 13
Official documents linked from their sources — offer documents as filed with SEBI (sebi.gov.in), annual reports and earnings-call transcripts as published on BSE (bseindia.com) and NSE (nseindia.com). Links open the source's own hosting; nothing is re-hosted here.
Index membership
27 indices
NSE weights are a free-float market-cap-share estimate, not NSE’s own published (and sometimes capped) index weight. BSE weights are BSE’s own published index weight, not an estimate. Indices without weight data are listed without one, in alphabetical order after the weighted ones.
Narayana Hrudayalaya plans to add around 500 beds in Delhi by FY29
Narayana Hrudayalaya Ltd. plans to add approximately 500 beds in Delhi by fiscal year 2029 as part of its expansion strategy in the national capital. This addition is included in the company's projected capital expenditure program through 2029, which totals around INR 30 billion. The expansion aims to address the shortage of hospital beds in Delhi and meet the significant healthcare demand in North India.